E-drug: Re: Sulphamethoxypyridazine/Pyrimethamine
----------------------------------------------------------
We have received an application for the marketing authorisation of the above
product in the treatment of malaria.
Anybody having information pertaining to this, kindly avail to us .
Fancis Otim
Drug Regulatory Officer
National Dtug Authority
nda@imul.com
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.